2 Actually Profitable Pot Stocks To Buy Before Trump's Cannabis Rescheduling

2026-01-30 09:05:00 ET

The hazy future of cannabis stocks in the U.S. is clearing, since the Trump Administration issued an Executive Order on Dec. 18 instructing the Attorney General to change marijuana from a Schedule 1 drug to Schedule 3. In the short term, there is still tons of red tape before any schedule change becomes legally effective. And even then, it is not the same as federally legalizing marijuana.

Ultimately, this policy change would mean Internal Revenue Code 280E would no longer apply to cannabis businesses, meaning they could deduct business expenses such as payroll and benefits, rent and facilities costs, marketing and advertising, and other overhead expenses. The bottom line: this change would make cannabis businesses more profitable.

There are other catalysts smoldering, too. Pennsylvania and Florida, two of the larger medical-use sales states, are nearing adult-use sales, as are Virginia and Minnesota, while other limited medical marijuana and adult-use states are expanding their programs. The two public companies ready to benefit most are the rare ones that are already turning a profit, notably, Green Thumb Industries (OTC: GTBIF) and NewLake Capital Partners (OTC: NLCP) .

Continue reading